These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18678299)

  • 1. Comparison of serum lipid values in subjects with and without the metabolic syndrome.
    Cordero A; Laclaustra M; León M; Casasnovas JA; Grima A; Luengo E; Ordoñez B; Bergua C; Bes M; Pascual I; Alegría E;
    Am J Cardiol; 2008 Aug; 102(4):424-8. PubMed ID: 18678299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.
    Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E
    Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
    Khan SH; Khan FA; Ijaz A; Sattar A; Dilawar M; Hashim R
    J Ayub Med Coll Abbottabad; 2008; 20(3):17-22. PubMed ID: 19610507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men.
    Cordero A; Andrés E; Ordoñez B; León M; Laclaustra M; Grima A; Luengo E; Moreno J; Bes M; Pascual I; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Am J Cardiol; 2009 Nov; 104(10):1393-7. PubMed ID: 19892056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
    Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena.
    Gentile M; Panico S; Jossa F; Mattiello A; Ubaldi S; Marotta G; Pauciullo P; Rubba P
    Clin Chim Acta; 2008 Feb; 388(1-2):179-83. PubMed ID: 18035055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.
    Kim BJ; Kim TY; Koh JM; Kim HK; Park JY; Lee KU; Shong YK; Kim WB
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):152-60. PubMed ID: 18494864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
    Marotta T; Russo BF; Ferrara LA
    Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population.
    Taverna MJ; Martínez-Larrad MT; Frechtel GD; Serrano-Ríos M
    Eur J Endocrinol; 2011 Apr; 164(4):559-67. PubMed ID: 21262912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profile cutoff values for predicting hypertension in an Iranian population (ROC curve analysis).
    Chehrei A; Sadrnia S; Samanianpour P; Soltani P; Mashayekhim N; Fani A
    Med Sci Monit; 2007 Feb; 13(2):CR100-4. PubMed ID: 17261981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study.
    Qader SS; Shakir YA; Nyberg P; Samsioe G
    Climacteric; 2008; 11(6):475-82. PubMed ID: 18991074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
    McLaughlin T; Reaven G; Abbasi F; Lamendola C; Saad M; Waters D; Simon J; Krauss RM
    Am J Cardiol; 2005 Aug; 96(3):399-404. PubMed ID: 16054467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Mälarstig A; Brismar K; Hamsten A; Fisher RM; Hellénius ML
    Clin Sci (Lond); 2009 Mar; 116(6):507-12. PubMed ID: 18816247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different metabolic syndrome classifications on the metabolic syndrome prevalence in a young Middle Eastern population.
    Chedid R; Gannagé-Yared MH; Khalifé S; Halaby G; Zoghbi F
    Metabolism; 2009 Jun; 58(6):746-52. PubMed ID: 19446111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study.
    Pitsavos C; Panagiotakos DB; Skoumas J; Papadimitriou L; Stefanadis C
    Angiology; 2008; 59(3):335-41. PubMed ID: 18388068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic risk factors associated with erosive esophagitis.
    Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.